[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pentaerythritol Market Size, Share & Trends Analysis By Product (Mono- Pentaerythritol, Di-Pentaerythritol), By Application (Paints & Coatings, Lubricants, Plasticizers), By Region, And Segment Forecasts, 2024 - 2030

September 2024 | 100 pages | ID: PD5F1F511C32EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Pediatric Diabetes Therapeutic Market Growth & Trends

The global pediatric diabetes therapeutic market size is anticipated to reach USD 22.14 billion by 2030, growing at a CAGR of 13.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the rising prevalence of diabetes among children and the increasing focus on early diagnosis and effective management. The International Diabetes Federation (IDF) estimates that in 2022, out of the 8.75 million people living with type 1 diabetes (T1D) worldwide, only 1.52 million were under the age of 20. This surge is largely due to genetic predisposition, environmental factors, and changes in lifestyle patterns.

Technological advancements in diabetes management are anticipated to positively impact market growth. Innovations such as continuous glucose monitors (CGMs), insulin pumps, and artificial pancreas systems enable better glucose control, reducing the risk of complications. For example, in June 2023, the U.S. FDA approved Synjardy (a combination of metformin hydrochloride and empagliflozin) and Jardiance (empagliflozin) for use in children aged 10 and older with type 2 diabetic (T2D), as an adjunct to diet and exercise for better blood sugar control. This approval is expected to significantly enhance treatment options for pediatric with T2D, encouraging broader adoption of these medications in clinical practice. It marks a critical step in expanding access to effective therapies for younger patients, leading to improved disease management and better long-term health outcomes.

Furthermore, the growing awareness and early diagnosis of disease in children have led to an increase in the adoption of various treatment options, including insulin therapies, biguanides, GLP-1 receptor agonists, and SGLT2 inhibitors. The market is also driven by supportive government initiatives and policies aimed at improving access to diabetic care for children. As the global children population continues to rise, along with the increasing prevalence of diabetes, the demand for diabetic treatment is expected to grow significantly during the forecast period.

Pediatric Diabetes Therapeutic Market Report Highlights
  • The type 1 segment held the largest revenue share of 79.32% in 2023. This can be attributed to the increasing incidence and prevalence of type 1 disease and high demand for new therapy treatment across worldwide.
  • In treatment, the insulin segment is held the largest share of 35.88% of the market in 2023. This can be attributed to the development and commercialization of novel delivery systems to deliver insulin safely and effectively to children’s patients without harm.
  • In route of administration, the parenteral segment is held the largest share of 62.50% of the market in 2023. This can be attributed to the growing approval of new subcutaneous and intravenous medicine for treatment of pediatric diabetes patient.
  • In distribution channel, the retail pharmacies segment is held the largest share of 47.49% of the market in 2023. This can be attributed to its advantages such as easy accessibility and availability of medication to refill prescriptions of pediatric patients for diabetes treatment.
  • North America dominated the market in 2023 with a share of 41.49%, owing to factors such as advanced healthcare infrastructure, increasing prevalence of diabetic in children, and favorable regulatory and reimbursement for clinical trial and treatment.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

CHAPTER 3. PENTAERYTHRITOL MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
3.4. Pentaerythritol Market Analysis Tools
  3.4.1. Porter’s Analysis
    3.4.1.1. Bargaining power of the suppliers
    3.4.1.2. Bargaining power of the buyers
    3.4.1.3. Threats of substitution
    3.4.1.4. Threats from new entrants
    3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
    3.4.2.1. Political landscape
    3.4.2.2. Economic and Social landscape
    3.4.2.3. Technological landscape
    3.4.2.4. Environmental landscape
    3.4.2.5. Legal landscape

CHAPTER 4. PENTAERYTHRITOL MARKET: PRODUCT ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Pentaerythritol Market: Product Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
4.3. Mono-Pentaerythritol
  4.3.1. Mono-Pentaerythritol Feed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
4.4. Di-Pentaerythritol
  4.4.1. Di-Pentaerythritol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
4.5. Tri-Pentaerythritol
  4.5.1. Tri-Pentaerythritol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

CHAPTER 5. PENTAERYTHRITOL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Pentaerythritol Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
5.3. Paints & Coatings
  5.3.1. Paints & Coatings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
5.4. Lubricants
  5.4.1. Lubricants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
5.5. Plasticizer
  5.5.1. Plasticizer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
5.6. Explosives
  5.6.1. Explosives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
5.7. Agriculture
  5.7.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
5.8. Others
  5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

CHAPTER 6. PENTAERYTHRITOL MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

6.1. Pentaerythritol Market Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
6.2. North America
  6.2.1. North America Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.2.2. U.S.
    6.2.2.1. U.S. Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.2.3. Canada
    6.2.3.1. Canada Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.2.4. Mexico
    6.2.4.1. Mexico Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
6.3. Europe
  6.3.1. Europe Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.3.2. UK
    6.3.2.1. UK Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.3.3. Germany
    6.3.3.1. Germany Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.3.4. France
    6.3.4.1. France Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.3.5. Italy
    6.3.5.1. Italy Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.3.6. Spain
    6.3.6.1. Spain Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
6.4. Asia Pacific
  6.4.1. Asia Pacific Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.4.2. China
    6.4.2.1. China Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.4.3. Japan
    6.4.3.1. Japan Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.4.4. India
    6.4.4.1. India Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.4.5. South Korea
    6.4.5.1. South Korea Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
6.5. Latin America
  6.5.1. Latin America Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.5.2. Brazil
    6.5.2.1. Brazil Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.5.3. Argentina
    6.5.3.1. Argentina Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
6.6. Middle East and Africa
  6.6.1. Middle East and Africa Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.2. Saudi Arabia
    6.6.2.1. Saudi Arabia Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  6.6.3. South Africa
    6.6.3.1. South Africa Pentaerythritol Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
  7.4.1. Ercros SA
    7.4.1.1. Participant’s Overview
    7.4.1.2. Financial Performance
    7.4.1.3. Product Benchmarking
    7.4.1.4. Recent Developments/ Strategic Initiatives
  7.4.2. KH Chemicals
    7.4.2.1. Participant’s Overview
    7.4.2.2. Financial Performance
    7.4.2.3. Product Benchmarking
    7.4.2.4. Recent Developments/ Strategic Initiatives
  7.4.3. Perstorp
    7.4.3.1. Participant’s Overview
    7.4.3.2. Financial Performance
    7.4.3.3. Product Benchmarking
    7.4.3.4. Recent Developments/ Strategic Initiatives
  7.4.4. Chemanol
    7.4.4.1. Participant’s Overview
    7.4.4.2. Financial Performance
    7.4.4.3. Product Benchmarking
    7.4.4.4. Recent Developments/ Strategic Initiatives
  7.4.5. HUBEI YIHUA CHEMICAL INDUSTRY CO., LTD
    7.4.5.1. Participant’s Overview
    7.4.5.2. Financial Performance
    7.4.5.3. Product Benchmarking
    7.4.5.4. Recent Developments/ Strategic Initiatives
  7.4.6. Chifeng Ruiyang Chemical Co., Ltd
    7.4.6.1. Participant’s Overview
    7.4.6.2. Financial Performance
    7.4.6.3. Product Benchmarking
    7.4.6.4. Recent Developments/ Strategic Initiatives
  7.4.7. Henan Pengcheng Group
    7.4.7.1. Participant’s Overview
    7.4.7.2. Financial Performance
    7.4.7.3. Product Benchmarking
    7.4.7.4. Recent Developments/ Strategic Initiatives
  7.4.8. Samyang Chemical Corporation
    7.4.8.1. Participant’s Overview
    7.4.8.2. Financial Performance
    7.4.8.3. Product Benchmarking
    7.4.8.4. Recent Developments/ Strategic Initiatives
  7.4.9. Solventis
    7.4.9.1. Participant’s Overview
    7.4.9.2. Financial Performance
    7.4.9.3. Product Benchmarking
    7.4.9.4. Recent Developments/ Strategic Initiatives
  7.4.10. Yuntianhua Group Co., Ltd.
    7.4.10.1. Participant’s Overview
    7.4.10.2. Financial Performance
    7.4.10.3. Product Benchmarking
    7.4.10.4. Recent Developments/ Strategic Initiative


More Publications